Association between mitochondrial DNA and cognitive impairment in schizophrenia: study protocol for a Mexican population

References

• Jahshan C, Heaton RK, Golshan S, Cadenhead KS. Course of neurocognitive deficits in the prodrome and first episode of schizophrenia. Neuropsychology. 2010;24(1):109–120. doi:10.1037/a001679120063952
   PubMed Web of Science ®Google Scholar
• Shapiro DI, Marenco S, Spoor EH, Egan MF, Weinberger DR, Gold JM. The premorbid adjustment scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings. Schizophr Res. 2009;112(1–3):136–142. doi:10.1016/j.schres.2009.04.00719410430
   PubMed Web of Science ®Google Scholar
• Fisher M, Loewy R, Carter C, et al. Neuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophrenia. Schizophr Bull. 2015;41(1):250–258. doi:10.1093/schbul/sbt23224444862
   PubMed Web of Science ®Google Scholar
• Mantovani LM, Teixeira AL, Salgado JV. Functional capacity: a new framework for the assessment of everyday functioning in schizophrenia. Braz J Psychiatry. 2015;37(3):249–255. doi:10.1590/1516-4446-2014-155126376057
   PubMed Web of Science ®Google Scholar
• Strassnig MT, Raykov T, O’Gorman C, et al. Determinants of different aspects of everyday outcome in schizophrenia: the roles of negative symptoms, cognition, and functional capacity. Schizophr Res. 2015;165(1):76–82. doi:10.1016/j.schres.2015.03.03325868935
   PubMed Web of Science ®Google Scholar
• Charlson FJ, Ferrari AJ, Santomauro DF, et al. Global epidemiology and burden of schizophrenia: findings from the Global Burden of Disease Study 2016. Schizophr Bull. 2018;44(6):1195–1203. doi:10.1093/schbul/sby05829762765
   PubMed Web of Science ®Google Scholar
• Kumar P, Efstathopoulos P, Millischer V, et al. Mitochondrial DNA copy number is associated with psychosis severity and anti-psychotic treatment. Sci Rep. 2018;8(1):12743. doi:10.1038/s41598-018-31122-030143692
   PubMed Web of Science ®Google Scholar
• Li Z, Hu M, Zong X, et al. Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naive schizophrenia. Sci Rep. 2015;5:18553. doi:10.1038/srep1855326680692
   PubMed Web of Science ®Google Scholar
• Kageyama Y, Kasahara T, Kato M, et al. The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression. J Affect Disord. 2018;233:15–20. doi:10.1016/j.jad.2017.06.00128633757
   PubMed Web of Science ®Google Scholar
• Soleimani R, Shokrgozar S, Fallahi M, Kafi H, Kiani M. An investigation into the prevalence of cognitive impairment and the performance of older adults in Guilan province. J Med Life. 2018;11(3):247–253. doi:10.25122/jml-2018-001730364719
   PubMedGoogle Scholar
• Yang Z, Abdul Rashid NA, Quek YF, et al. Montreal cognitive assessment as a screening instrument for cognitive impairments in schizophrenia. Schizophr Res. 2018;199:58–63. doi:10.1016/j.schres.2018.03.00829549976
   PubMed Web of Science ®Google Scholar
• Kilian S, Burns JK, Seedat S, et al. Factors moderating the relationship between childhood trauma and premorbid adjustment in first-episode schizophrenia. PLoS One. 2017;12(1):e0170178. doi:10.1371/journal.pone.017017828107388
   PubMed Web of Science ®Google Scholar
• Cannon-Spoor HE, Potkin SG, Wyatt RJ. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull. 1982;8(3):470–484. doi:10.1093/schbul/8.3.4707134891
   PubMed Web of Science ®Google Scholar
• Emsley R, Rabinowitz J, Torreman M; Group R-I-EPGW. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res. 2003;61(1):47–57.12648735
   PubMed Web of Science ®Google Scholar
• Lindqvist D, Wolkowitz OM, Picard M, et al. Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder. Neuropsychopharmacology. 2018;43(7):1557–1564. doi:10.1038/s41386-017-0001-929453441
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Mirsky AF. Evolving notions of schizophrenia as a developmental neurocognitive disorder. J Int Neuropsychol Soc. 2017;23(9–10):881–892. doi:10.1017/S135561771700111429198285
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Cherkerzian S, Goldstein JM, Agnew-Blais J, Tsuang MT, Buka SL. Neuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family Studies. Psychol Med. 2013;43(1):119–131. doi:10.1017/S003329171200077322575089
   PubMed Web of Science ®Google Scholar
• Seidman LJ, Shapiro DI, Stone WS, et al. Association of neurocognition with transition to psychosis: baseline functioning in the second phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry. 2016;73(12):1239–1248. doi:10.1001/jamapsychiatry.2016.247927806157
   PubMed Web of Science ®Google Scholar
• Piskulic D, Liu L, Cadenhead KS, et al. Social cognition over time in individuals at clinical high risk for psychosis: findings from the NAPLS-2 cohort. Schizophr Res. 2016;171(1–3):176–181. doi:10.1016/j.schres.2016.01.01726785807
   PubMed Web of Science ®Google Scholar
• Grassi S, Orsenigo G, Serati M, Caletti E, Altamura AC, Buoli M. Cognitive correlates of neuroimaging abnormalities in the onset of schizophrenia: a case report. World J Psychiatry. 2017;7(2):128–132. doi:10.5498/wjp.v7.i2.12828713691
   PubMed Web of Science ®Google Scholar
• Olivero P, Lozano C, Sotomayor-Zárate R, et al. Proteostasis and mitochondrial role on psychiatric and neurodegenerative disorders: current perspectives. Neural Plast. 2018;2018:6798712. doi:10.1155/2018/679871230050571
   PubMed Web of Science ®Google Scholar
• Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev. 2015;48:10–21. doi:10.1016/j.neubiorev.2014.11.00525446950
   PubMed Web of Science ®Google Scholar
• Ben-Shachar D. Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target. Schizophr Res. 2017;187:3–10. doi:10.1016/j.schres.2016.10.02227802911
   PubMed Web of Science ®Google Scholar
• West AP. Mitochondrial dysfunction as a trigger of innate immune responses and inflammation. Toxicology. 2017;391:54–63. doi:10.1016/j.tox.2017.07.01628765055
   PubMed Web of Science ®Google Scholar
• Johnsen E, Fathian F, Kroken RA, et al. The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis. BMC Psychiatry. 2016;16:60. doi:10.1186/s12888-016-0769-x26973142
   PubMed Web of Science ®Google Scholar
• Contreras-Shannon V, Heart DL, Paredes RM, et al. Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells. PLoS One. 2013;8(3):e59012. doi:10.1371/journal.pone.005901223527073
   PubMed Web of Science ®Google Scholar
• Wojciak P, Remlinger-Molenda A, Rybakowski J. Stages of the clinical course of schizophrenia – staging concept. Psychiatr Pol. 2016;50(4):717–730. doi:10.12740/PP/5872327847923
   PubMed Web of Science ®Google Scholar
• Radic K, Curkovic M, Bagaric D, Vilibic M, Tomic A, Zivkovic M. Ethical approach to prevention of schizophrenia – concepts and challenges. Psychiatr Danub. 2018;30(1):35–40. doi:10.24869/psyd.2018.3529546856
   PubMed Web of Science ®Google Scholar